Consumption of sedative drugs during colonoscopy D12.8 K58
Conditions
Interventions
Group 1: Colonoscopy with ultrathin colonoscope (Olympus PCF-Y0020-L)
Group 2: Colonoscopy with standard colonoscope (Olympus CF-H180AL)
Sponsors
EVK Evangelisches Krankenhaus Düsseldorf
Medizinische Klinik
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Willingness to accept sedation on demand; ASA 1 or 2, age = 18 years; indication screening, anemia, history of polypectomy, suspected gastrointestinal bleeding, abdominal complaints, irregular bowel habits
Exclusion criteria
Exclusion criteria: Patiens without informed consent, who wish deep sedation from the beginning, who wish no sedation from the beginning, with a history of partial colectomy, with previously known colorectal carcinoma, with previously known inflammatory bowel disease, with pregnancy or breastfeeding, with scheduled polypectomy, ASA 3 or 4
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consumption of propofol (mg) until colonoscope reaches caecum | — |
Secondary
| Measure | Time frame |
|---|---|
| Level of sedation (definition according to the guidelines of the "Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten") while colonoscope is being pushed forward: time 1 - colonoscope reaches colon transversum; time 2 - colonoscope reaches caecum. | — |
Countries
Germany
Contacts
Public ContactBrigitte Schumacher
EVK Evangelisches Krankenhaus Düsseldorf Medizinische Klinik
Outcome results
None listed